As per MRFR analysis, the India Extracorporeal Membrane Oxygenation Machine Market Size was estimated at 88 (USD Million) in 2023. The India Extracorporeal Membrane Oxygenation Machine Market Industry is expected to grow from 120(USD Million) in 2024 to 240 (USD Million) by 2035. The India Extracorporeal Membrane Oxygenation Machine Market CAGR (growth rate) is expected to be around 6.504% during the forecast period (2025 - 2035).
The India Extracorporeal Membrane Oxygenation Machine Market is experiencing notable market trends driven by an increasing prevalence of respiratory and cardiac conditions. As more patients require advanced life-support systems, healthcare providers are investing in ECMO machines to enhance patient outcomes. Government initiatives aimed at improving healthcare infrastructure, especially in critical care, further support this growth.
Facilities across India are looking to upgrade their medical equipment to meet international standards, which bolsters the demand for innovative ECMO technology. Opportunities to be explored include the potential for partnerships between local manufacturers and international companies to develop cost-effective ECMO solutions tailored for the Indian market. The Indian healthcare system is transitioning to home and community health models, which has opened up new opportunities for portable ECMO units.
Additionally, the increasing emphasis on telemedicine presents an opportunity for remote monitoring solutions, which will improve the ECMO treatment process. A growing awareness among healthcare professionals regarding the advantages of ECMO has resulted in an increase in the number of training programs and certification courses. Recent trends reflect this trend.
The increasing prevalence of advanced ECMO systems in India is facilitating the accessibility of these instruments to healthcare providers by providing improved user interfaces and automated functions. Furthermore, there is a growing emphasis on the integration of artificial intelligence and miniaturisation, which has the potential to transform patient care in critical situations. The ECMO market in India is poised to undergo a transformation as a result of this transition to more advanced technology and innovative practices.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The rise in respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and pneumonia due to air pollution and changing lifestyle is a significant driver for the India Extracorporeal Membrane Oxygenation Machine Market Industry. According to the Ministry of Health and Family Welfare in India, about 10% of the population suffers from various forms of respiratory ailments.
This alarming statistic translates to approximately 136 million individuals in need of advanced respiratory support, including Extracorporeal Membrane Oxygenation machines. Leading healthcare provider organizations, like Apollo Hospitals, are investing in advanced medical technologies, including ECMO machines, to cater to this rising demand, thereby propelling market growth.
This trend is expected to expand as India's healthcare infrastructure continues to improve and modernize to meet the populace's requirements.
The Indian government's ongoing efforts to enhance healthcare infrastructure significantly contribute to the growth of the India Extracorporeal Membrane Oxygenation Machine Market Industry. Initiatives such as the Ayushman Bharat scheme target improving healthcare access for over 500 million citizens by providing financial support for hospital treatments.
As a result, hospitals are increasingly equipped with sophisticated technologies, including ECMO systems, to improve critical care services. According to the National Health Authority, there has been a notable increase in funding and resources allocated to critical care units across the country, which has directly influenced the adoption of advanced medical devices like ECMO machines.
These initiatives serve to bolster the healthcare sector and address the increasing cases of severe respiratory conditions, driving market growth.
The growing prevalence of cardiovascular diseases (CVD) in India is another vital driver for the India Extracorporeal Membrane Oxygenation Machine Market Industry. Research from the Indian Heart Association indicates that cardiovascular diseases account for nearly 30% of deaths in India, amounting to approximately 1.5 million fatalities annually.
This rampant increase necessitates innovative treatment options, including Extracorporeal Membrane Oxygenation, to improve survival rates in severe cases. Major players like Fortis Healthcare are actively investing in ECMO technologies as a part of their advanced treatment protocols for cardiac patients.
As the incidence of cardiac diseases rises, hospitals are likely to expand ECMO availability, directly influencing market growth.
Rapid technological advancements in Extracorporeal Membrane Oxygenation systems are propelling demand in the India Extracorporeal Membrane Oxygenation Machine Market Industry. Innovations such as miniaturized ECMO systems and improved biocompatibility materials are enhancing performance and user-friendliness.
These improvements are crucial in a country with diverse healthcare facilities, granting access to critical care even in smaller hospitals. According to the healthcare technology assessment guidelines issued by the Indian Medical Association, there is a growing demand for cutting-edge medical devices that combine performance with efficiency.
Enhanced ECMO technologies help meet this growing demand, resulting in increased adoption as healthcare providers recognize their importance in treating critical patients.
The India Extracorporeal Membrane Oxygenation Machine Market demonstrates a robust Application segment, which plays a pivotal role in critical care settings across the country. This market is primarily categorized into three major areas Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass.
Cardiac Support is instrumental in providing life-saving therapy for patients suffering from severe cardiac issues, allowing for extended time for recovery and evaluation of other treatment options. In India, the increased prevalence of cardiovascular diseases contributes significantly to the demand for advanced cardiac care technologies, making this application not only vital but also one of the predominant drivers of market growth.
Respiratory Support is another critical facet of this market, particularly with rising respiratory diseases, complications from the COVID-19 pandemic, and other viral infections impacting lung function. The effectiveness of Extracorporeal Membrane Oxygenation machines in providing adequate oxygenation and carbon dioxide removal is a game changer, emphasizing its importance in emergency and intensive care units within India's healthcare framework.
The advancement in technologies related to Respiratory Support often leads to improved patient outcomes, ensuring a notable presence in the overarching market. Cardiopulmonary Bypass, while less frequently discussed, plays an essential role during surgical procedures, especially in cardiac surgeries.
The ability of these machines to temporarily take over the function of the heart and lungs allows surgeons to conduct intricate procedures with enhanced safety. As India continues to escalate its healthcare infrastructure, the demand for reliable and efficient Cardiopulmonary Bypass systems will undoubtedly rise, thereby reinforcing the significance of this application within the India Extracorporeal Membrane Oxygenation Machine Market.
Overall, these applications collectively underline the strategic importance and operational effectiveness of Extracorporeal Membrane Oxygenation Machines in treating life-threatening conditions, particularly within India. The growing healthcare investments, increasing awareness of advanced treatment modalities, and rising patient volumes are solidifying the market's potential across these crucial areas of application.
As the dynamics of the healthcare sector continue to evolve, the integration and advancement of ECMO technology stand to greatly enhance the quality of cardiovascular and respiratory care available to patients.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The India Extracorporeal Membrane Oxygenation Machine Market is largely driven by its applications in various end-user settings, including hospitals, ambulatory surgical centers, and home care settings. Hospitals are often the primary users due to their capacity to handle critical care patients, providing advanced respiratory support for those with severe heart and lung issues.
Ambulatory surgical centers play a significant role by facilitating quicker surgical procedures that require immediate post-operative support, thereby enhancing patient recovery times. Additionally, home care settings are gaining prominence, allowing patients with chronic respiratory problems to receive effective treatment in a comfortable environment, which aligns with the Indian government's initiatives to promote home healthcare services.
The increasing prevalence of cardiovascular diseases and respiratory disorders in India is a critical growth driver, amplifying the demand for extracorporeal membrane oxygenation machines across these sectors. This combined interest reflects a positive trajectory in the India Extracorporeal Membrane Oxygenation Machine Market as it adapts to the evolving healthcare landscape. Each setting contributes uniquely to the overall landscape, catering to a diverse patient population with specific needs.
The India Extracorporeal Membrane Oxygenation Machine Market exhibits a diverse range of product types, notably encompassing Venoarterial ECMO, Venovenous ECMO, and Arteriovenous ECMO. Venoarterial ECMO is primarily utilized in critical care settings for patients experiencing severe cardiac and respiratory failure, highlighting its significance in life-saving scenarios.
This form of ECMO provides both cardiac and respiratory support, thereby dominating emergency care protocols in India, where the prevalence of cardiovascular diseases is on the rise. Venovenous ECMO, on the other hand, is particularly effective for patients suffering from severe respiratory failure, allowing for oxygenation without the need for full cardiac support.
This type of ECMO is increasingly recognized for its role in treating conditions like COVID-19-related acute respiratory distress syndrome (ARDS) in Indian hospitals. Arteriovenous ECMO serves a more niche role, often used in specialized situations such as for patients needing both hemodialysis and respiratory support.
As the demand for advanced medical technologies grows, particularly in urban centers, understanding these product types is essential for healthcare professionals and policymakers in enhancing patient outcomes within the India Extracorporeal Membrane Oxygenation Machine Market. Moreover, the increasing number of ECMO-trained personnel and facilities will likely drive further adoption of these technologies, reflecting the market's growth potential.
The Component segment of the India Extracorporeal Membrane Oxygenation Machine Market encompasses critical elements such as Membrane Oxygenators, Blood Pumps, and Heat Exchangers, which collectively play a vital role in the functionality and efficiency of ECMO systems. Membrane Oxygenators are essential for gas exchange, enabling oxygenation of blood while removing carbon dioxide, thus supporting patients with severe cardiac or respiratory failure.
Blood Pumps are significant as they maintain circulation and ensure effective blood flow, which is crucial during long-term procedures. Heat Exchangers, on the other hand, regulate blood temperature, thereby preventing hypothermia and optimizing patient outcomes.
The demand for sophisticated components has surged with the increasing prevalence of chronic diseases and the need for advanced medical technologies in India. As the healthcare infrastructure expands and evolves, driven by government initiatives aimed at improving health services, these components are positioned to dominate the market.
The ongoing advancements in materials and technology highlight the importance of innovation in this segment, paving the way for enhanced performance and patient care in critical situations. With a focus on high-quality components, the India Extracorporeal Membrane Oxygenation Machine Market is expected to thrive, reflecting the growing emphasis on specialized medical treatments in the country.
The India Extracorporeal Membrane Oxygenation Machine Market has been witnessing significant growth driven by various factors such as the increasing prevalence of respiratory diseases, advancements in healthcare technologies, and a rising number of cardiac surgeries. The competitive landscape of this market is characterized by both national and international players striving to innovate and expand their offerings to cater to the growing demand for ECMO machines.
Understanding the competitive dynamics is vital for stakeholders aiming to identify opportunities and mitigate challenges as the market evolves. Companies are focusing on enhancing product features, reliability, and efficiency while also establishing strategic alliances and partnerships to broaden their market reach and improve patient outcomes.
Asahi Kasei Medical has established a notable presence in the India Extracorporeal Membrane Oxygenation Machine Market through its commitment to quality and innovation. The company is well-regarded for its comprehensive range of ECMO products, which are designed to meet the stringent requirements of healthcare providers.
Key strengths of Asahi Kasei Medical include its strong research and development capabilities that drive the continuous improvement of its products, ensuring they align with the latest medical standards and technological advancements. Moreover, the company benefits from its established supply chain and distribution networks within India, enabling it to effectively serve hospitals and healthcare facilities across various regions.
This strategic positioning allows Asahi Kasei Medical to maintain a competitive edge in the market, addressing the increasing demands for better respiratory support systems.
LivaNova has also made significant strides in the India Extracorporeal Membrane Oxygenation Machine Market, positioning itself as a key player in providing advanced medical solutions. The company offers a range of ECMO devices that are known for their cutting-edge technology and reliability, which are essential for critical care patients.
LivaNova's strengths lie in its innovative product lines, robust clinical support, and effective marketing strategies, which continue to solidify its market position. The company has engaged in strategic mergers and acquisitions to bolster its product offerings and expand its footprint in the Indian market.
Through these endeavors, LivaNova aims to enhance its service delivery to healthcare providers, ensuring they have access to state-of-the-art ECMO solutions that facilitate improved patient outcomes in a critical care setting.
In recent developments, the India Extracorporeal Membrane Oxygenation Machine Market has been witnessing a notable increase in demand due to the rising incidence of respiratory illnesses and cardiovascular diseases, particularly in the wake of the COVID-19 pandemic. Asahi Kasei Medical and LivaNova are among the key players enhancing their market presence, while Medtronic and Nihon Kohden Corporation continue to innovate in technology.
Current affairs indicate significant growth in market valuation, with several companies, including Fresenius Medical Care and Terumo Corporation, expanding their product offerings and geographical reach to cater to the growing healthcare needs. Notably, in June 2023, Getinge announced a strategic partnership with a leading Indian hospital chain to enhance ECMO treatment capabilities, further solidifying its market position.
The competitive landscape is also marked by an acquisition by Jiangsu Tiansheng Medical Devices in July 2023, acquiring a local company to strengthen its foothold in India. This surge in capacity building and strategic collaborations among key players is significantly reshaping the ECMO machine market in India, ensuring better health outcomes for critically ill patients.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 88.0(USD Million) |
| MARKET SIZE 2024 | 120.0(USD Million) |
| MARKET SIZE 2035 | 240.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.504% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Asahi Kasei Medical, LivaNova, Medtronic, Nihon Kohden Corporation, Fresenius Medical Care, Cleveland Medical Devices, Glenmed, CardioMed, Terumo Corporation, Mediwar, Xenios AG, Jiangsu Tiansheng Medical Devices, Mediatrix, Nipro Corporation, Getinge |
| SEGMENTS COVERED | Application, End User, Product Type, Component |
| KEY MARKET OPPORTUNITIES | Increasing prevalence of respiratory diseases, Growing adoption in critical care settings, Advancements in ECMO technology, Expanding healthcare infrastructure, Rising awareness among medical professionals |
| KEY MARKET DYNAMICS | Rising prevalence of respiratory diseases, Increasing investment in healthcare infrastructure, Advancements in ECMO technology, Growing awareness among healthcare professionals, Expanding applications in critical care |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The market is expected to be valued at 120.0 million USD in 2024.
By 2035, the market is anticipated to reach a value of 240.0 million USD.
The market is projected to grow at a CAGR of 6.504% during the period from 2025 to 2035.
The Cardiac Support segment is projected to grow significantly, with an expected value of 100.0 million USD by 2035.
The Respiratory Support application is anticipated to reach a value of 80.0 million USD by 2035.
The Cardiopulmonary Bypass application is expected to grow to a market value of 60.0 million USD by 2035.
Key players in the market include Asahi Kasei Medical, LivaNova, Medtronic, and Fresenius Medical Care, among others.
In 2024, the Cardiac Support segment is expected to hold the highest market share valued at 50.0 million USD.
Emerging trends include increased focus on cardiac and respiratory support due to growing patient populations.
Challenges may include regulatory hurdles and high costs associated with advanced medical technologies.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
